Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 147

1.

Rabbit haemorrhagic disease virus type 2 in hares in England.

Bell DJ, Davis JP, Gardner M, Barlow AM, Rocchi M, Gentil M, Wilson RJ.

Vet Rec. 2019 Jan 26;184(4):127-128. doi: 10.1136/vr.l337. No abstract available.

PMID:
30683789
2.

Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML).

Gentil M, Hugues P, Desterke C, Telliam G, Sloma I, Souza LEB, Baykal S, Artus J, Griscelli F, Guerci A, Johnson-Ansah H, Foudi A, Bennaceur-Griscelli A, Turhan AG.

PLoS One. 2018 Aug 9;13(8):e0200923. doi: 10.1371/journal.pone.0200923. eCollection 2018.

3.

Factors influencing the development of primary care data collection projects from electronic health records: a systematic review of the literature.

Gentil ML, Cuggia M, Fiquet L, Hagenbourger C, Le Berre T, Banâtre A, Renault E, Bouzille G, Chapron A.

BMC Med Inform Decis Mak. 2017 Sep 25;17(1):139. doi: 10.1186/s12911-017-0538-x. Review.

4.

CMV-specific T-cell immunity in solid organ transplant recipients at low risk of CMV infection. Chronology and applicability in preemptive therapy.

Mena-Romo JD, Pérez Romero P, Martín-Gandul C, Gentil MÁ, Suárez-Artacho G, Lage E, Sánchez M, Cordero E.

J Infect. 2017 Oct;75(4):336-345. doi: 10.1016/j.jinf.2017.05.020. Epub 2017 Jun 13.

PMID:
28599954
5.

[Prevalence of Dog circovirus in healthy and diarrhoeic dogs].

Gentil M, Gruber AD, Müller E.

Tierarztl Prax Ausg K Kleintiere Heimtiere. 2017 Apr 19;45(2):89-94. doi: 10.15654/TPK-160701. Epub 2017 Feb 23. German.

PMID:
28229163
6.

Hepatitis C Treatment With Direct-Acting Antivirals in Kidney Transplant: Preliminary Results From a Multicenter Study.

Gentil MA, González-Corvillo C, Perelló M, Zarraga S, Jiménez-Martín C, Lauzurica LR, Alonso A, Franco A, Hernández-Marrero D, Sánchez-Fructuoso A.

Transplant Proc. 2016 Nov;48(9):2944-2946. doi: 10.1016/j.transproceed.2016.07.034.

PMID:
27932113
7.

Kidney Transplantation Results in Very Highly Sensitized Patients Included in a Virtual Crossmatch Program: Analysis of Kidney Pairs.

Mazuecos A, Alvarez A, Nieto A, Gentil MA, Cabello M, Rodriguez-Benot A, Gracia C, Gonzalez F, Castro P, Alonso M.

Transplant Proc. 2016 Nov;48(9):2899-2902. doi: 10.1016/j.transproceed.2016.07.051.

PMID:
27932102
8.

Non-Heart-Beating Donor Kidney Transplantation Survival Is Similar to Donation After Brain Death: Comparative Study With Controls in a Regional Program.

Gentil MA, Castro de la Nuez P, Gonzalez-Corvillo C, de Gracia MC, Cabello M, Mazuecos MA, Rodriguez-Benot A, Ballesteros L, Osuna A, Alonso M.

Transplant Proc. 2016 Nov;48(9):2867-2870. doi: 10.1016/j.transproceed.2016.07.036.

PMID:
27932094
9.

Medium-Term Renal Function in a Large Cohort of Stable Kidney Transplant Recipients Converted From Twice-Daily to Once-Daily Tacrolimus.

Guirado L, Burgos D, Cantarell C, Fernández A, Franco A, Gentil MÁ, Mazuecos A, Torregrosa JV, Huertas EG, Ruiz JC, Plumed JS, Paul J, Lauzurica R, Zárraga S, Osuna A, Jiménez C, Alonso Á, Rodríguez A, Bardají B, Hernández D.

Transplant Direct. 2015 Aug 5;1(7):e24. doi: 10.1097/TXD.0000000000000536. eCollection 2015 Aug.

10.

Use of antibodies neutralizing epithelial cell infection to diagnose patients at risk for CMV Disease after transplantation.

Blanco-Lobo P, Cordero E, Martín-Gandul C, Gentil MA, Suárez-Artacho G, Sobrino M, Aznar J, Pérez-Romero P.

J Infect. 2016 May;72(5):597-607. doi: 10.1016/j.jinf.2016.02.008. Epub 2016 Feb 24.

PMID:
26920791
11.

Impact of Asystolic Donations in Kidney Transplant Activity From Cadaveric Donors in Andalusia.

Gentil MA, Gonzalez-Corvillo C, Castro P, Ruiz-Esteban P, Gracia-Guindo C, Garcia-Alvarez T, Agüera ML, Ballesteros L, Osuna A, Alonso M.

Transplant Proc. 2015 Nov;47(9):2584-6. doi: 10.1016/j.transproceed.2015.09.046.

PMID:
26680042
12.

Survival of Kidney Allograft of Donors after Circulatory Death Is Similar to Donors after Brain Death: Experience in a Regional Program.

Gentil MA, Castro P, Ballesteros L, Gracia-Guindo MC, Cabello M, Mazuecos MA, Rodriguez-Benot A, Gonzalez-Corvillo C, Borrego J, Ortega AO, Alonso M.

Transplant Proc. 2015 Nov;47(9):2572-4. doi: 10.1016/j.transproceed.2015.09.045.

PMID:
26680038
13.

Constitutive autophagy contributes to resistance to TP53-mediated apoptosis in Epstein-Barr virus-positive latency III B-cell lymphoproliferations.

Pujals A, Favre L, Pioche-Durieu C, Robert A, Meurice G, Le Gentil M, Chelouah S, Martin-Garcia N, Le Cam E, Guettier C, Raphaël M, Vassilev LT, Gaulard P, Codogno P, Lipinski M, Wiels J.

Autophagy. 2015;11(12):2275-87. doi: 10.1080/15548627.2015.1115939.

14.

Polymorphisms in EGFR and IL28B are associated with spontaneous clearance in an HCV-infected Iranian population.

Carapito R, Poustchi H, Kwemou M, Untrau M, Sharifi AH, Merat S, Haj-Sheykholeslami A, Jabbari H, Esmaili S, Michel S, Toussaint J, Le Gentil M, Ansari-Moghaddam A, Radosavljevic M, Etemadi A, Georgel P, Malekzadeh R, Bahram S.

Genes Immun. 2015 Dec;16(8):514-8. doi: 10.1038/gene.2015.38. Epub 2015 Sep 17.

PMID:
26378651
15.

Real-time ultrasound-guided epidural catheter insertion in obese parturients.

Gnaho A, Nau A, Gentil ME.

Can J Anaesth. 2015 Nov;62(11):1226-7. doi: 10.1007/s12630-015-0441-9. Epub 2015 Aug 1. No abstract available. Erratum in: Can J Anaesth. 2015 Nov;62(11):1228.

PMID:
26232030
16.

On the genetics of the Silk Route: association analysis of HLA, IL10, and IL23R-IL12RB2 regions with Behçet's disease in an Iranian population.

Carapito R, Shahram F, Michel S, Le Gentil M, Radosavljevic M, Meguro A, Abdollahi BS, Inoko H, Ota M, Davatchi F, Bahram S.

Immunogenetics. 2015 Jun;67(5-6):289-93. doi: 10.1007/s00251-015-0841-6. Epub 2015 May 5.

PMID:
25940109
17.

A de novo ADCY5 mutation causes early-onset autosomal dominant chorea and dystonia.

Carapito R, Paul N, Untrau M, Le Gentil M, Ott L, Alsaleh G, Jochem P, Radosavljevic M, Le Caignec C, David A, Damier P, Isidor B, Bahram S.

Mov Disord. 2015 Mar;30(3):423-7. doi: 10.1002/mds.26115. Epub 2014 Dec 27.

PMID:
25545163
18.

Genetic evidence of a precisely tuned dysregulation in the hypoxia signaling pathway during oncogenesis.

Couvé S, Ladroue C, Laine E, Mahtouk K, Guégan J, Gad S, Le Jeune H, Le Gentil M, Nuel G, Kim WY, Lecomte B, Pagès JC, Collin C, Lasne F, Benusiglio PR, Bressac-de Paillerets B, Feunteun J, Lazar V, Gimenez-Roqueplo AP, Mazure NM, Dessen P, Tchertanov L, Mole DR, Kaelin W, Ratcliffe P, Richard S, Gardie B.

Cancer Res. 2014 Nov 15;74(22):6554-64. doi: 10.1158/0008-5472.CAN-14-1161. Epub 2014 Nov 4.

19.

Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy.

Martín-Gandul C, Pérez-Romero P, Blanco-Lobo P, Benmarzouk-Hidalgo OJ, Sánchez M, Gentil MA, Bernal C, Sobrino JM, Rodríguez-Hernández MJ, Cordero E; Spanish Network for Research in Infectious Diseases (REIPI).

Transpl Int. 2014 Oct;27(10):1060-8. doi: 10.1111/tri.12378. Epub 2014 Aug 20.

20.

[Cinacalcet in the management of normocalcaemic secondary hyperparathyroidism after kidney transplantation: one-year follow-up multicentre study].

Torregrosa JV, Morales E, Díaz JM, Crespo J, Bravo J, Gómez G, Gentil MA, Rodríguez-Benot A, Rodríguez-García M, López-Jiménez V, Gutiérrez-Dalmau Á, Jimeno L, Pérez-Sáez MJ, Romero R, Gómez-Alamillo C; Grupo de Estudio CINAREN.

Nefrologia. 2014;34(1):62-8. doi: 10.3265/Nefrologia.pre2013.Aug.12183. Spanish.

21.

Cinacalcet for hypercalcaemic secondary hyperparathyroidism after renal transplantation: a multicentre, retrospective, 3-year study.

Torregrosa JV, Morales E, Díaz JM, Crespo J, Bravo J, Gómez G, Gentil MÁ, Rodríguez Benot A, García MR, Jiménez VL, Gutiérrez Dalmau A, Jimeno L, Sáez MJ, Romero R, Gómez Alamillo C; CINAREN Study Group.

Nephrology (Carlton). 2014 Feb;19(2):84-93. doi: 10.1111/nep.12186.

PMID:
24428216
22.

Pharmacokinetic modeling of enterohepatic circulation of mycophenolic acid in renal transplant recipients.

Colom H, Lloberas N, Andreu F, Caldés A, Torras J, Oppenheimer F, Sanchez-Plumed J, Gentil MA, Kuypers DR, Brunet M, Ekberg H, Grinyó JM.

Kidney Int. 2014 Jun;85(6):1434-43. doi: 10.1038/ki.2013.517. Epub 2014 Jan 8.

23.

Proteinuria as a predictive factor in the evolution of kidney transplantation.

Borrego J, Mazuecos A, Gentil MA, Cabello M, Rodríguez A, Osuna A, Pérez MA, Castro P, Alonso M.

Transplant Proc. 2013;45(10):3627-9. doi: 10.1016/j.transproceed.2013.10.025.

PMID:
24314978
24.

Status of the down-regulated canine testis using two different GNRH agonist implants in comparison with the juvenile testis.

Goericke-Pesch S, Gentil M, Spang A, Kowalewski MP, Failing K, Hoffmann B.

Reproduction. 2013 Oct 21;146(6):517-26. doi: 10.1530/REP-13-0195. Print 2013 Dec.

PMID:
24019508
25.

Early-onset anemia after kidney transplantation is an independent factor for graft loss: a multicenter, observational cohort study.

Pascual J, Jiménez C, Franco A, Gil M, Obrador-Mulet AR, Gentil MA, Romero R, Grinyó JM, Hernández D, Morales JM, Pallardó LM, Serón D, Arias M, Campistol JM; ANEMIART Study Group.

Transplantation. 2013 Oct 27;96(8):717-25. doi: 10.1097/TP.0b013e31829f162e.

PMID:
23896555
26.

Clinical profile and post-transplant anaemia in renal transplant recipients restarting dialysis after a failed graft: changing trends between 2001 and 2009.

Arias M, Hernández D, Guirado L, Campistol JM, Sánchez Plumed JA, Gómez E, Gentil MA, de Santiago C.

Clin Kidney J. 2013 Apr;6(2):156-63. doi: 10.1093/ckj/sfs181. Epub 2013 Feb 3.

27.

Do drug transporter (ABCB1) SNPs and P-glycoprotein function influence cyclosporine and macrolides exposure in renal transplant patients? Results of the pharmacogenomic substudy within the symphony study.

Llaudó I, Colom H, Giménez-Bonafé P, Torras J, Caldés A, Sarrias M, Cruzado JM, Oppenheimer F, Sánchez-Plumed J, Gentil MÁ, Ekberg H, Grinyó JM, Lloberas N.

Transpl Int. 2013 Feb;26(2):177-86. doi: 10.1111/tri.12018. Epub 2012 Dec 7.

28.

Testing for hereditary spherocytosis: a French experience.

Mayeur-Rousse C, Gentil M, Botton J, Thibaut MF, Guitton C, Picard V.

Haematologica. 2012 Dec;97(12):e48-9; author reply e52. doi: 10.3324/haematol.2012.074070. No abstract available.

29.

Restart of steroidogenesis in dogs during recrudescence of testicular function following downregulation with a GnRH-agonist implant.

Gentil M, Hoffmann B, Spang A, Failing K, Goericke-Pesch S.

Cell Tissue Res. 2012 Dec;350(3):513-23. doi: 10.1007/s00441-012-1506-5. Epub 2012 Oct 9.

PMID:
23053053
30.

Deficient long-term response to pandemic vaccine results in an insufficient antibody response to seasonal influenza vaccination in solid organ transplant recipients.

Cordero E, Aydillo TA, Perez-Ordoñez A, Torre-Cisneros J, Lara R, Segura C, Gentil MA, Gomez-Bravo MA, Lage E, Pachon J, Perez-Romero P.

Transplantation. 2012 Apr 27;93(8):847-54. doi: 10.1097/TP.0b013e318247a6ef.

PMID:
22377789
31.

Impact of cold ischemia time on initial graft function and survival rates in renal transplants from deceased donors performed in Andalusia.

Pérez Valdivia MA, Gentil MA, Toro M, Cabello M, Rodríguez-Benot A, Mazuecos A, Osuna A, Alonso M.

Transplant Proc. 2011 Jul-Aug;43(6):2174-6. doi: 10.1016/j.transproceed.2011.06.047.

PMID:
21839225
32.

Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients.

Guirado L, Cantarell C, Franco A, Huertas EG, Fructuoso AS, Fernández A, Gentil MA, Rodríguez A, Paul J, Torregrossa JV, Rodríguez A, Alonso A, Hernández D, Burgos D, Jiménez C, Jimeno L, Lauzurica R, Mazuecos A, Osuna A, Plumed JS, Ruiz JC, Zárraga S; GREAT Study Group.

Am J Transplant. 2011 Sep;11(9):1965-71. doi: 10.1111/j.1600-6143.2011.03571.x. Epub 2011 Jun 10.

33.

Influence of MRP2 on MPA pharmacokinetics in renal transplant recipients-results of the Pharmacogenomic Substudy within the Symphony Study.

Lloberas N, Torras J, Cruzado JM, Andreu F, Oppenheimer F, Sánchez-Plumed J, Gentil MÁ, Brunet M, Ekberg H, Grinyó JM; Spanish Pharmacogenetic Symphony Substudy Group.

Nephrol Dial Transplant. 2011 Nov;26(11):3784-93. doi: 10.1093/ndt/gfr130. Epub 2011 Mar 22.

PMID:
21427078
34.

Therapeutic effect of the acquisition of cytomegalovirus-specific immune response during preemptive treatment.

Benmarzouk-Hidalgo OJ, Cisneros JM, Cordero E, Martín-Peña A, Sanchez B, Martin-Gandul C, Gentil MA, Gomez-Bravo MA, Lage E, Perez-Romero P.

Transplantation. 2011 Apr 27;91(8):927-33. doi: 10.1097/TP.0b013e3182115ba2.

PMID:
21358366
35.

Renal Transplant Register of Andalusia, 2010 Report: survival in relation to the factors used in recipient selection.

Gentil MA, Pérez-Valdivia MA, Rodriguez-Benot A, Sola E, Osuna A, Mazuecos MA, Bedoya R, Borrego J, Castro P, Alonso M.

Transplant Proc. 2010 Oct;42(8):3130-3. doi: 10.1016/j.transproceed.2010.05.138.

PMID:
20970627
36.

Results of living kidney donation in Andalusia: 2006-2009.

Pérez-Valdivia MA, Ramos MT, Gentil MA, Osuna A, Mazuelos A, Sola E, Rodríguez-Benot A.

Transplant Proc. 2010 Oct;42(8):3128-9. doi: 10.1016/j.transproceed.2010.05.124.

PMID:
20970626
37.

Erythropoietin resistance as surrogate marker of graft and patient survival in renal transplantation: 3-year prospective multicenter study.

Gomez-Alamillo C, Fernández-Fresnedo G, Ortega F, Campistol JM, Gentil MA, Arias M; Investigators of ARES Study.

Transplant Proc. 2010 Oct;42(8):2935-7. doi: 10.1016/j.transproceed.2010.07.043.

PMID:
20970575
38.

Renal transplantation in patients with hepatitis C virus antibody. A long national experience.

Morales JM, Marcén R, Andres A, Domínguez-Gil B, Campistol JM, Gallego R, Gutierrez A, Gentil MA, Oppenheimer F, Samaniego ML, Muñoz-Robles J, Serón D.

NDT Plus. 2010 Jun;3(Suppl_2):ii41-ii46.

39.

Effect of long-term steroid withdrawal in renal transplant recipients: a retrospective cohort study.

Gonzalez-Molina M, Gentil MA, Burgos D, Cabello M, Cobelo C, Bustamante J, Errasti P, Franco A, Hernández D.

NDT Plus. 2010 Jun;3(Suppl_2):ii32-ii36.

40.

Open-label trial: effect of weekly risedronate immediately after transplantation in kidney recipients.

Torregrosa JV, Fuster D, Gentil MA, Marcen R, Guirado L, Zarraga S, Bravo J, Burgos D, Monegal A, Muxí A, García S.

Transplantation. 2010 Jun 27;89(12):1476-81. doi: 10.1097/TP.0b013e3181dc13d0.

PMID:
20393402
41.

Improvement in late renal allograft survival between 1990 and 2002 in Spain: results from a multicentre case-control study.

Moreso F, Alonso A, Gentil MA, González-Molina M, Capdevila L, Marcén R, Pascual J, Serón D; Spanish Late Allograft Dysfunction Study Group.

Transpl Int. 2010 Sep;23(9):907-13. doi: 10.1111/j.1432-2277.2010.01075.x. Epub 2010 Mar 11.

42.

Efficacy of low doses of pamidronate in osteopenic patients administered in the early post-renal transplant.

Torregrosa JV, Fuster D, Monegal A, Gentil MA, Bravo J, Guirado L, Muxí A, Cubero J.

Osteoporos Int. 2011 Jan;22(1):281-7. doi: 10.1007/s00198-010-1197-2. Epub 2010 Mar 13.

PMID:
20229199
43.

Why anguish?

Gentil V, Gentil ML.

J Psychopharmacol. 2011 Jan;25(1):146-7. doi: 10.1177/0269881109354134. Epub 2009 Dec 9. No abstract available.

PMID:
20007412
44.

Increase in malignancies as cause of death in renal transplant patients.

Mazuecos A, Muñoz Terol JM, García Alvárez T, Sola E, Rodríguez Benot A, Dsuna A, Bedoya R, Gentil MA.

Transplant Proc. 2009 Jul-Aug;41(6):2159-62. doi: 10.1016/j.transproceed.2009.05.029.

PMID:
19715861
45.

Regional survey of patient survival after cadaver renal transplant failure.

Gentil MA, Muñoz-Terol JM, Pérez-Valdivia MA, Sola E, Bedoya R, Castro P, Alonso M.

Transplant Proc. 2009 Jul-Aug;41(6):2089-91. doi: 10.1016/j.transproceed.2009.06.171.

PMID:
19715839
46.

Are we still making progress in patient survival after kidney transplantation? Results of a regional registry.

Gentil MA, Pérez-Valdivia MA, Muñoz-Terol JM, Borrego J, Mazuecos A, Osuna A, Rodríguez-Benot A, Alonso M.

Transplant Proc. 2009 Jul-Aug;41(6):2085-8. doi: 10.1016/j.transproceed.2009.05.028.

PMID:
19715838
47.

Prevention of cytomegalovirus disease using pre-emptive treatment after solid organ transplant in patients at high risk for cytomegalovirus infection.

Benmarzouk-Hidalgo OJ, Cordero E, Martín-Peña A, García-Prado E, Gentil MA, Gomez-Bravo MA, Barrera-Pulido L, Cisneros JM, Perez-Romero P.

Antivir Ther. 2009;14(5):641-7.

PMID:
19704166
48.

The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy.

Grinyó JM, Ekberg H, Mamelok RD, Oppenheimer F, Sánchez-Plumed J, Gentil MA, Hernandez D, Kuypers DR, Brunet M.

Nephrol Dial Transplant. 2009 Jul;24(7):2269-76. doi: 10.1093/ndt/gfp162. Epub 2009 Apr 8.

PMID:
19357111
49.

Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.

Alvarez-Márquez A, Aguilera I, Gentil MA, Caro JL, Bernal G, Fernández Alonso J, Acevedo MJ, Cabello V, Wichmann I, Gonzalez-Escribano MF, Núñez-Roldán A.

Transplantation. 2009 Jan 15;87(1):94-9. doi: 10.1097/TP.0b013e31818bd790.

PMID:
19136897
50.

Treatment of BK virus-associated nephropathy with Cidofovir in renal transplantation.

Cabello V, Margarit N, Díaz Pedrero M, Bernal G, Pereira P, Gentil MA.

Transplant Proc. 2008 Nov;40(9):2930-2. doi: 10.1016/j.transproceed.2008.09.002.

PMID:
19010151

Supplemental Content

Loading ...
Support Center